STEERLife Collaborates with Ole Miss on Continuous Manufacturing Initiative

Source: STEERLife

Jan 10, 2017

STEERLife, creator proprietary continuous processing technology, and the University of Mississippi, announced an agreement for collaborative research using fractional lobe processing. The move aims to develop advanced pharmaceutical applications including semi solid formulations for dermal and transdermal applications and provide solutions for the industry to change the way medicines are manufactured, applied and administered through continuous manufacturing.

According to STEERLife, it will invest a significant amount over four years, providing a proprietary co-rotating twin screw technology platform and equipment with fractional lobe technology. The partnership will also engage students pursuing their Master's, Doctoral and Postdoctoral studies on research based projects and mentor them.

The agreement comes at a time when the FDA and regulatory agencies in other countries are increasingly driving the adoption of continuous manufacturing.

“We are honored to be associated with the University of Mississippi,” said Dipak Chattaraj, Chairman of STEERAmerica Inc. “We are committed to changing the way medicines are made and taken. The collaboration provides access to cutting edge technology that could revolutionize the batch to continuous paradigm. Further it also allows for the creation of innovative drug delivery platforms that are far more convenient to patients.”

“Our mission at the University has always been to improve health, well-being and quality of life of individuals and communities by educating students, pharmacy practitioners and pharmaceutical scientists, conducting research, and engaging in service,” said Dr. S. Narasimha Murthy, professor of pharmaceutics and drug delivery at the University's School of Pharmacy. “The partnership with STEERLife gives our students direct access to cutting edge technology that can advance knowledge and strengthen the understanding of continuous processing. It opens up a world of new opportunities in innovative pharmaceutical applications by allowing our students to work with newer, more sensitive and valuable materials that could positively impact consumers.”

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments